摘要
中枢神经系统 (CNS) 疾病和大脑肿瘤的治疗具有挑战性,它们是全球最常见的死亡原因之一。将药物输送到大脑是有问题的,因为血脑屏障 (BBB) 有效地阻止了大分子(包括药物)从血液到中枢神经系统的运输。纳米粒子 (NP) 介导的药物递送作为一种克服这一困难的技术受到了广泛关注。特别是,脂质体 NPs 是携带和递送药物穿过 BBB 并进入 CNS 的有希望的候选者。脂质体易于制备、高度可生物降解和生物相容性。脂质体可以很容易地用各种配体进行修饰,以实现高效和有针对性的药物递送。脂质体可以促进细胞对药物的吸收增加,并可以降低外排转运蛋白去除药物的程度。脂质体可以装载多种药物和生物活性物质。在这篇综述中,我们将总结与基于脂质体的策略相关的研究的最新进展,以实现跨 BBB 的药物递送。
关键词: 血脑屏障、药物靶向、双配体修饰脂质体、转铁蛋白、细胞穿透肽、中枢神经系统。
Current Medicinal Chemistry
Title:Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain
Volume: 28 Issue: 21
关键词: 血脑屏障、药物靶向、双配体修饰脂质体、转铁蛋白、细胞穿透肽、中枢神经系统。
摘要: Disorders of the central nervous system (CNS) and tumors of the brain are challenging to treat, and they rank amongst the most common causes of death worldwide. The delivery of drugs to the brain is problematic because the blood-brain barrier (BBB) effectively arrests the transport of large molecules (including drugs) from the blood to the CNS. Nanoparticle (NP)-mediated drug delivery has received much interest as a technique to overcome this difficulty. In particular, liposome NPs are promising candidates to carry and deliver drugs across the BBB and into the CNS. Liposomes are easy to prepare, highly biodegradable, and biocompatible. Liposomes can be easily modified with various ligands to enable efficient and targeted drug delivery. Liposomes can promote increased cellular uptake of drugs and can reduce the extent to which efflux transporters can remove drugs. Liposomes can be loaded with a wide range of drugs and biologically active substances. In this review, we will summarize recent advances in research relating to liposome-based strategies to enable drug delivery across the BBB.
Export Options
About this article
Cite this article as:
Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain, Current Medicinal Chemistry 2021; 28 (21) . https://dx.doi.org/10.2174/0929867328666201218121728
DOI https://dx.doi.org/10.2174/0929867328666201218121728 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
Current Alzheimer Research Diversified Thiazole Substituted Coumarins and Chromones as Non- Cytotoxic ROS and NO Inhibitors
Letters in Drug Design & Discovery Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Current Pharmaceutical Design Virulence on the Fly: Drosophila melanogaster as a Model Genetic Organism to Decipher Host-Pathogen Interactions
Current Drug Targets Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics Gene Therapy for Parkinsons Disease: Progress and Challenges
Current Gene Therapy Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis
Current Pharmaceutical Design VEGF Signaling Regulates Cofilin and the Arp2/3-complex within the Axonal Growth Cone
Current Neurovascular Research Heat Shock Proteins Protect Against Ischemia and Inflammation Through Multiple Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) Recent Patents in Autophagy and Immune Response
Recent Patents on Inflammation & Allergy Drug Discovery Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors
Current Topics in Medicinal Chemistry Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: Alzheimer’s Disease - Mechanisms, Drug Targets and Alternative Treatments)
Current Topics in Medicinal Chemistry Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy
Current Alzheimer Research Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Neuroprotective Mechanisms as Treatment Strategy in Alzheimers disease
Current Medicinal Chemistry - Central Nervous System Agents Molecular Mechanism Aspect of ER Stress in Alzheimer's Disease: Current Approaches and Future Strategies
Current Drug Targets Introduction (Transient Receptor Potential TRP Channels as Therapeutic Drug Targets: Next Round!)
Current Topics in Medicinal Chemistry Benzimidazole Derivatives as Centerally Acting Agents
Current Drug Therapy Can Apolipoproteins and Complement Factors be Biomarkers of Alzheimer’s Disease?
Current Alzheimer Research